Concentrated Acetate Haemodialysis Solution Formulation WA 1 (Cat 1911) New Zealand - engelsk - Medsafe (Medicines Safety Authority)

concentrated acetate haemodialysis solution formulation wa 1 (cat 1911)

fresenius medical care australia pty ltd (nz) - calcium chloride dihydrate 7.7 g/l; magnesium chloride hexahydrate 3.6 g/l; potassium chloride 2.6 g/l; sodium acetate trihydrate 181 g/l (as sodium hydroxide and acetic acid); sodium chloride 196.4 g/l - dialysis solution - active: calcium chloride dihydrate 7.7 g/l magnesium chloride hexahydrate 3.6 g/l potassium chloride 2.6 g/l sodium acetate trihydrate 181 g/l (as sodium hydroxide and acetic acid) sodium chloride 196.4 g/l excipient: purified water

Magnesiumsulfaat Kalceks 100 mg/ml oplossing voor injectie/infusie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

magnesiumsulfaat kalceks 100 mg/ml oplossing voor injectie/infusie

as kalceks krustpils iela 53 lv 1057 riga (letland) - magnesiumsulfaat 7-water (e 518) 100 mg/ml - oplossing voor injectie of infusie - natriumhydroxide (e 524) ; water voor injectie ; zwavelzuur (e 513) - magnesium sulfate

Kaliumchloride 0.15% w/v - Natriumchloride 0.9% w/v Fresenius Kabi, oplossing voor infusie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

kaliumchloride 0.15% w/v - natriumchloride 0.9% w/v fresenius kabi, oplossing voor infusie

fresenius kabi nederland b.v. amersfoortseweg 10 e 3712 bc huis ter heide - kaliumchloride 1,5 mg/ml ; natriumchloride 9 mg/ml ; samenstelling overeenkomend met chloride (cl-) 174 mmol/l ; kalium (k+) 20 mmol/l ; natrium (na+) 154 mmol/l - oplossing voor infusie - natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - electrolytes

Kaliumchloride 0.3% w/v - Natriumchloride 0.9% w/v Fresenius Kabi, oplossing voor infusie Nederland - nederlandsk - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

kaliumchloride 0.3% w/v - natriumchloride 0.9% w/v fresenius kabi, oplossing voor infusie

fresenius kabi nederland b.v. amersfoortseweg 10 e 3712 bc huis ter heide - kaliumchloride 3 mg/ml ; natriumchloride 9 mg/ml ; samenstelling overeenkomend met chloride (cl-) 194 mmol/l ; kalium (k+) 40 mmol/l ; natrium (na+) 154 mmol/l - oplossing voor infusie - natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - electrolytes

SODIUM BICARBONATE 500 MG Israel - engelsk - Ministry of Health

sodium bicarbonate 500 mg

rekah pharmaceutical industry ltd, israel - sodium bicarbonate - tablets - sodium bicarbonate 500 mg - sodium bicarbonate - sodium bicarbonate - antacid.

CALCIUM ARROW 500 mg, comprimé à sucer Frankrike - fransk - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

calcium arrow 500 mg, comprimé à sucer

arrow generiques - calcium élément 500 mg sous forme de : carbonate de calcium 1250 mg - comprimé - 500 mg - pour un comprimé > calcium élément 500 mg sous forme de : carbonate de calcium 1250 mg - calcium / element mineral - calcium / element mineral(a: appareil digestif et métabolisme)ce médicament contient du calcium. il est indiqué : en cas de carence en calcium suite à une augmentation des besoins (croissance, grossesse, allaitement) ;, en traitement d'appoint des décalcifications osseuses chez le sujet âgé, ou après la ménopause, une corticothérapie, une immobilisation prolongée après reprise de la mobilité.

MAGNESIUM SULFATE- magnesium sulfate heptahydrate injection, solution USA - engelsk - NLM (National Library of Medicine)

magnesium sulfate- magnesium sulfate heptahydrate injection, solution

fresenius kabi norge as - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 80 mg in 1 ml - magnesium sulfate in water for injection is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively.  when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.  however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

MAGNESIUM SULFATE IN 5% DEXTROSE- magnesium sulfate heptahydrate injection, solution USA - engelsk - NLM (National Library of Medicine)

magnesium sulfate in 5% dextrose- magnesium sulfate heptahydrate injection, solution

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 1 g in 100 ml - magnesium sulfate in 5% dextrose injection, usp is indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively.  when used judiciously it effectively prevents and controls the convulsions of eclampsia without producing deleterious depression of the central nervous system of the mother or infant.  however, other effective drugs are available for this purpose. intravenous magnesium should not be given to mothers with toxemia of pregnancy during the two hours preceding delivery.

MAGNESIUM SULFATE injection, solution USA - engelsk - NLM (National Library of Medicine)

magnesium sulfate injection, solution

hospira, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

MAGNESIUM SULFATE injection, solution USA - engelsk - NLM (National Library of Medicine)

magnesium sulfate injection, solution

hospira, inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia. in such cases, the serum magnesium (mg++ ) level is usually below the lower limit of normal (1.5 to 2.5 meq/liter) and the serum calcium (ca++ ) level is normal (4.3 to 5.3 meq/liter) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection, usp is also indicated for the prevention and control of seizures (convulsions) in pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.